SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10095Bob, ELN management has no respect from Wall Street(and rightly so) and with thArthur Radley-2/12/2009
10094Hmmmm... So my take that the long term value of this company from an FA standpoSI Bob-2/12/2009
10093<i> Tysabri company that could eventually lose out to competing therapies tom pope-2/12/2009
10092I'm too lazy to do this myself if someone else already has, but has anyone dSI Bob-2/12/2009
10091Graham, IMO..ELN management has lost any respect that they might have had. McCauArthur Radley-2/9/2009
10090All is not well in Elanville... Jack Schuler of Crabtree partenrs with 1.5% ofpgo-neil-2/9/2009
10089MS Patients Treated with TYSABRI Remain Free of Disease Activity for Two Years, sim1-2/9/2009
10088This morning's BIIB Q report they admit reaching revenue goals for Tysabri wArthur Radley-2/6/2009
10087Another case of PML reported today. 5 cases diagnosed since re introduction on Lee39-2/6/2009
10086graham, thank you for those posts. Sure makes catching up easy. fred hayesfred hayes-2/3/2009
10085Hi Tom, You are welcome. One other point I forgot last night... Plex is not witpgo-neil-2/3/2009
10084Thanks, very detailed and relevant to patching my ignorance.tom pope-2/3/2009
10083The current issue of "Neurology" has some articles on Ty and PML. Onepgo-neil-2/3/2009
10082Thanks, Fred, that's what I thought. I bought a small position the other daytom pope-2/2/2009
10081Tom, I doubt that it's significant. It's very likely a reference to the fred hayes-2/2/2009
10080Was there any significant news after hours? CNBC had something about T clearing tom pope-2/2/2009
10079Merck Serono Reports Positive Phase-3 Results for Cladribine in RRMS: siliconinDewDiligence_on_SI-1/23/2009
10078finance.yahoo.com Opexa is short on cash, but data looks promising......previouArthur Radley-1/20/2009
10077With the current turmoil in the European financial markets this will be a hard dArthur Radley-1/19/2009
10076UPDATE 1-Denmark's Lundbeck interested in Elan - report (Adds Lundbeck, ansim1-1/19/2009
10075reuters.com UPDATE 1-Wyeth Alzeheimer drug moving ahead in Europe Wed Jan 14, 2steve kammerer-1/15/2009
10074Tysabri Growth Rate Dropped by Half in 4Q08 vs 3Q08: siliconinvestor.comDewDiligence_on_SI-1/13/2009
10073Elan sounds like it may indeed be for sale. Pretty hard to raise $500 million onfred hayes-1/13/2009
10072Elan not for sale altho "approached consistently". Selling non-core stfred hayes-1/10/2009
10071Elan Advances on Speculation Pfizer May Seek Purchase (Update1) Email | Print | Saulamanca-1/8/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News